The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

Auteurs

Delbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E

  • Date de publication

    Augustus 2025

  • Type

    Article

  • Tijdschrift

    Eur J Nucl Med Mol Imaging

  • Naam van de onderzoeker

    VERCRUYSSEN MARIE

  • Hôpital

    Institut Jules Bordet

  • Dienst

    Hématologie

  • PMID

    40866646

  • DOI

    10.1007/s00259-025-07500-y